We are QbDVision

The team that believes every cure deserves to be delivered.

Every cure in development is a patient waiting. We exist to shorten the wait.

[

Team culture

]

Proud pharma geeks, united by one mission

We’re building the modern digital tools our industry needs to realize the full potential of its science. QbDVision, the industry’s first Digital CMC platform, accelerates the drug development cycle, increases the probability of technical success, and helps get cures to patients that much faster.

[

In it for the lifecycle

]

Implementation is just the beginning

We believe the people behind a platform matter as much as the platform itself. That belief shapes how we show up: domain experts who have lived pharmaceutical development and manufacturing and a success team that stays for the long run.

Our leadership team

Yash Sabharwal, PhD

Yash Sabharwal is an accomplished inventor, entrepreneur, and executive specializing in the funding and growth of early-stage technology companies focused on life science applications. He has started 3 companies and successfully exited his last two, bringing a wealth of strategic and tactical experience to the team.

Ryan Shillington

Ryan Shillington is a seasoned CTO with decades of experience in software development, process refinement, architecture, and quality control. There's very little about building software companies that he doesn't understand at every layer, from technical things like programming to hiring and managing large remote and diverse teams.

Luke Guerrero

Luke is an experienced technology leader with a background in growing teams, building software products, and running business operations. As Chief Marketing Officer at QbDVision, he leads marketing and brings operational and cross-industry experience to the company's brand and go-to-market.

Michael Stapleton, PhD

Michael Stapleton is a life sciences leader with success spanning leadership roles in software, consumables, instruments, services, consulting, and pharmaceuticals. He is a constant innovator, optimist, influencer, and digital thought leader identifying the next strategic challenge in life sciences, executing and operationalizing on high impact strategic plans to drive growth.

Phillip Johnson

Phillip Johnson brings over three decades of financial leadership and strategic expertise to his role as Chief Financial Officer at QbDVision. Since joining the company in March 2022, Phillip has leveraged his extensive experience in financial planning, risk management, capital raising, and operational improvement to drive sustainable growth and innovation in the organization.

Chas Peacock

Chas is a decades long veteran of technology who has led teams large and small across a wide variety of industries, from politics, e-commerce, developer tooling, and many others.

Our board of directors

Emma Cartmell

Emma is a distinguished healthcare leader who has served in multiple C-level positions for both public and private companies in the healthcare technology industry. She has developed M&A strategies for public and private companies on both the buy and sell-side, with investment targets of up to $1B.

Eric Engineer

Eric is a full-time Venture Partner at S3 Ventures, and board member of S3 portfolio companies Atmosphere, VUV Analytics, and CherryCircle Software, the parent company of QbDVision. He was previously CEO at Invodo (an S3 Ventures portfolio company), a partner at Sevin Rosen Funds, and held numerous product and sales roles at Microsoft.

Paxton Major

Paxton Major is a member of Northpond Ventures convergent technologies team. Paxton is a Board Observer at Scitara, Syapse, SimBioSys, NanoView, VieCure, SeluxDX, and other emerging growth companies. Prior to Northpond, Paxton was a consultant at Trinity Partners, a life science-focused strategy and management consultancy. Paxton earned a B.S. with honors in neurobiology from Brown University.

We’re here to help you deliver